Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-14
1996-04-02
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 111, 536114, 53612312, A61K 31715
Patent
active
055040799
ABSTRACT:
Modified yeast cell wall glucans are administered to patients who are at risk for infection due to imminent surgery, chemotherapy or other treatment which affects the immune system, in order to mobilize the cellular defense mechanisms and boost the immune response of the patient before, during and after the surgery, chemotherapy or other treatment.
REFERENCES:
patent: 4343784 (1982-08-01), Massot et al.
patent: 4739046 (1988-04-01), DiLuzio
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
Ostroff et al., "Manipulation of Yeast Glucan Structure: Molecular Weight, Branch Frequency and Branch Length", The Fermentor, 9(12):51, American Chemical Society, Abstract No. 19, (Aug. 1989).
J. K. Czop, Pathology and Immunopathology Research, 5:286-296 (1986).
N. R. DiLuzio et al., International Journal of Cancer, 24:773-779 (1979).
J. A. Cook et al., Survey of Immunological Research, 2:243-245 (1983).
W. Browder, Survey of Immunological Research, 2:299-301 (1983).
M. L. Patchen, Survey of Immunological Research, 2:237-242 (1983).
J. A. Cook et al., Infection and Immunity, 37(3):1261-1269 (1982).
T. W. Holbrook et al., American Journal of Tropical Medical Hygiene, 32(1):51-53 (1983).
T. W. Holbrook et al., American Journal of Tropical Medical Hygiene, 30(4):762-768 (1981).
J. A. Cook et al., Infection and Immunity, 40(3):1038-1043 (1983).
M. A. Chirigos et al., Cancer Research, 38:1085-1091 (1978).
J. A. Reynolds et al., Infection and Immunity, 20(1):51-57 (1980).
J. L. Benach et al., Infection and Immunity, 35(3):947-951 (1982).
E. R. Sherwood et al., International Journal of Immunopharmacology, 9(3):261-267 (1987).
International Search Report.
Easson, Jr. D. Davidson
Jamas Spiros
Ostroff Gary R.
Alpha-Beta Technology, Inc.
Knode Marian C.
Witz Jean C.
LandOfFree
Method for immune system activation by administration of a .beta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for immune system activation by administration of a .beta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for immune system activation by administration of a .beta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2016435